|Articles|February 1, 2020
- Pharmaceutical Executive-02-01-2020
- Volume 40
- Issue 2
Pharmaceutical Executive, February 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 6 years ago
Improving the Link from Lab to Physicianalmost 6 years ago
Engaging the New HCP in the Digital Worldalmost 6 years ago
Jay Galeota: A Better Way to Pharmaalmost 6 years ago
Surfacing Insights: AI and the Physicianalmost 6 years ago
Becoming a Pharma Industry Leaderalmost 6 years ago
Unlocking the Black Box of Pharma Pricing in Europealmost 6 years ago
The Risks and Rewards of Expedited Reviewalmost 6 years ago
Using Service to Drive Commercial Valuealmost 6 years ago
The Roots and Rise of Cell and Gene Therapyalmost 6 years ago
Pharma Outsourcing: Keys to Productivity in 2020sNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
4
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
5
